TY  - GEN
AU  - Lee,V W Y
AU  - Chau,T S
AU  - Chan,A K W
AU  - Lee,K K C
AU  - Waye,M M Y
AU  - Ling,T K W
AU  - Chan,F K L
TI  - Pharmacogenetics of esomeprazole or rabeprazole-based triple therapy in Helicobacter pylori eradication in Hong Kong non-ulcer dyspepsia Chinese subjects
SN  - 1365-2710
PY  - 2010///1217
KW  - 2-Pyridinylmethylsulfinylbenzimidazoles
KW  - administration & dosage
KW  - Adult
KW  - Amoxicillin
KW  - Anti-Bacterial Agents
KW  - Anti-Ulcer Agents
KW  - Aryl Hydrocarbon Hydroxylases
KW  - genetics
KW  - Asian People
KW  - Breath Tests
KW  - methods
KW  - Clarithromycin
KW  - Cytochrome P-450 CYP2C19
KW  - Drug Resistance, Bacterial
KW  - Dyspepsia
KW  - drug therapy
KW  - Esomeprazole
KW  - Female
KW  - Helicobacter Infections
KW  - Helicobacter pylori
KW  - drug effects
KW  - Hong Kong
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Mutation
KW  - Pharmacogenetics
KW  - Polymorphism, Genetic
KW  - Prospective Studies
KW  - Rabeprazole
KW  - Urea
KW  - metabolism
N1  - Publication Type: Comparative Study; Controlled Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/j.1365-2710.2009.01088.x
ER  -